Time for Informed Consent: The FDA Considers Risks of Power Morcellators in Fibroid Surgery

pathology from a uterine leiomyoma (fibroid); PLoS 2012; 7(11) e50058

Last week, a panel convened by the FDA deliberated over the risks and benefits of using power morcellators in gynecological surgery. In April, the agency issued an alert cautioning providers that the tools could spread malignant cells from an occult malignancy.